Form 4: CVS Health Director Acquires Deferred Stock Units

Alecia A. DeCoudreaux, a director of CVS Health Corp, acquired deferred stock units equivalent to 2,077.4764 shares of common stock on May 15, 2025, as part of the company's non-employee director compensation policy.

Summary

• On May 15, 2025, Alecia A. DeCoudreaux, a director at CVS Health Corp, acquired deferred stock units.
• The acquisition was made under the Issuer's 2017 Incentive Compensation Plan.
• The deferred stock units are equivalent to 2,077.4764 shares of CVS Health common stock.
• The price of the deferred stock units was valued at $60.47 per share.
• Following the transaction, DeCoudreaux directly owns 37,765.4382 shares of CVS Health common stock.
• The deferred stock units will be converted into shares of common stock in the future, as elected by the Reporting Person.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive as it reflects standard director compensation practices and aligns director interests with shareholders.

Positives

• The acquisition of deferred stock units aligns the director's interests with those of the shareholders.
• The compensation plan incentivizes directors to contribute to the long-term success of the company.

Future Outlook

The deferred stock units will be converted into shares of common stock in the future, as elected by the Reporting Person.

Industry Context

This filing is a routine disclosure related to director compensation and stock ownership, common in publicly traded companies.

Comparison to Industry Standards

• Director compensation packages often include deferred stock units to align director interests with shareholder value, similar to practices at companies like Walgreens Boots Alliance and UnitedHealth Group.
• The vesting and conversion terms of these units are typical for director compensation plans.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders by aligning director interests with long-term company performance.

Key Dates

Keywords

CVS Health, Director, Deferred Stock Units, Form 4, Beneficial Ownership, Incentive Compensation Plan, DECOUDREAUX ALECIA A